TL Catalog
  1. Tables
  2. Adverse Events
  3. TSFAE22A
  • Introduction

  • Index

  • Tables
    • Adverse Events
      • TSFAE01A
      • TSFAE01B
      • TSFAE02
      • TSFAE02A
      • TSFAE03
      • TSFAE03A
      • TSFAE04
      • TSFAE04A
      • TSFAE05
      • TSFAE05A
      • TSFAE06A
      • TSFAE06B
      • TSFAE07A
      • TSFAE07B
      • TSFAE08
      • TSFAE09
      • TSFAE10
      • TSFAE11
      • TSFAE12
      • TSFAE13
      • TSFAE14
      • TSFAE15
      • TSFAE16
      • TSFAE17A
      • TSFAE17B
      • TSFAE17C
      • TSFAE17D
      • TSFAE19A
      • TSFAE19B
      • TSFAE19C
      • TSFAE19D
      • TSFAE20A
      • TSFAE20B
      • TSFAE20C
      • TSFAE21A
      • TSFAE21B
      • TSFAE21C
      • TSFAE21D
      • TSFAE22A
      • TSFAE22B
      • TSFAE22C
      • TSFAE23A
      • TSFAE23B
      • TSFAE23C
      • TSFAE23D
      • TSFAE24A
      • TSFAE24B
      • TSFAE24C
      • TSFAE24D
      • TSFAE24F
      • TSFDTH01
    • Clinical Laboratory Evaluation
      • TSFLAB01
      • TSFLAB01A
      • TSFLAB02
      • TSFLAB02A
      • TSFLAB02B
      • TSFLAB03
      • TSFLAB03A
      • TSFLAB04A
      • TSFLAB04B
      • TSFLAB05
      • TSFLAB06
      • TSFLAB07
    • Demographic
      • TSIDEM01
      • TSIDEM02
      • TSIMH01
    • Disposition of Subjects
      • TSIDS01
      • TSIDS02
      • TSIDS02A
    • Electrocardiograms
      • TSFECG01
      • TSFECG01A
      • TSFECG02
      • TSFECG03
      • TSFECG04
      • TSFECG05
    • Exposure
      • TSIEX01
      • TSIEX02
      • TSIEX03
      • TSIEX04
      • TSIEX06
      • TSIEX07
      • TSIEX08
      • TSIEX09
      • TSIEX10
      • TSIEX11
    • Pharmacokinetics
      • TPK01A
      • TPK01B
      • TPK02
      • TPK03
    • Prior and Concomitant Therapies
      • TSICM01
      • TSICM02
      • TSICM03
      • TSICM04
      • TSICM05
      • TSICM06
      • TSICM07
      • TSICM08
    • Vital Signs and Physical Findings
      • TSFVIT01
      • TSFVIT01A
      • TSFVIT02
      • TSFVIT03
      • TSFVIT04
      • TSFVIT05
      • TSFVIT06
  • Listings
    • Adverse Events
      • LSFAE01
      • LSFAE02
      • LSFAE03
      • LSFAE04
      • LSFAE05
      • LSFAE06A
      • LSFAE06B
      • LSFDTH01
    • Clinical Laboratory Evaluation
      • LSFLAB01
    • Demographic
      • LSIDEM01
      • LSIDEM02
      • LSIMH01
    • Disposition of Subjects
      • LSIDS01
      • LSIDS02
      • LSIDS03
      • LSIDS04
      • LSIDS05
    • Electrocardiograms
      • LSFECG01
      • LSFECG02
    • Exposure
      • LSIEX01
      • LSIEX02
      • LSIEX03
    • Prior and Concomitant Therapies
      • LSICM01
    • Vital Signs and Physical Findings
      • LSFVIT01
      • LSFVIT02

  • Reproducibility

  • Changelog

On this page

  • Output
  • Edit this page
  • Report an issue
  1. Tables
  2. Adverse Events
  3. TSFAE22A

TSFAE22A

Subjects With Treatment-emergent Adverse Events by System Organ Class, Preferred Term, and Race


Output

  • Preview
Code
# Program Name: tsfae22a.R

# Prep Environment

library(envsetup)
library(tern)
library(dplyr)
library(rtables)
library(junco)

# Define script level parameters:

# - Define output ID and file location

tblid <- "TSFAE22a"
fileid <- tblid
tab_titles <- get_titles_from_file(input_path = '../../_data/', tblid)
string_map <- default_str_map


trtvar <- "TRT01A"
popfl <- "SAFFL"
combined_colspan_trt <- TRUE

if (combined_colspan_trt == TRUE) {
  # Set up levels and label for the required combined columns
  add_combo <- add_combo_facet(
    "Combined",
    label = "Combined",
    levels = c("Xanomeline High Dose", "Xanomeline Low Dose")
  )

  # choose if any facets need to be removed - e.g remove the combined column for placebo
  rm_combo_from_placebo <- cond_rm_facets(
    facets = "Combined",
    ancestor_pos = NA,
    value = " ",
    split = "colspan_trt"
  )

  mysplit <- make_split_fun(post = list(add_combo, rm_combo_from_placebo))
}

# Process Data:

adsl <- pharmaverseadamjnj::adsl %>%
  filter(!!rlang::sym(popfl) == "Y") %>%
  select(STUDYID, USUBJID, all_of(trtvar), all_of(popfl), RACE)

adae <- pharmaverseadamjnj::adae %>%
  filter(TRTEMFL == "Y") %>%
  select(USUBJID, TRTEMFL, AEBODSYS, AEDECOD, RACE)

adsl$colspan_trt <- factor(
  ifelse(adsl[[trtvar]] == "Placebo", " ", "Active Study Agent"),
  levels = c("Active Study Agent", " ")
)

colspan_trt_map <- create_colspan_map(
  adsl,
  non_active_grp = "Placebo",
  non_active_grp_span_lbl = " ",
  active_grp_span_lbl = "Active Study Agent",
  colspan_var = "colspan_trt",
  trt_var = trtvar
)

# Add total for Race - adsl
totalrace1 <- adsl %>%
  filter(RACE != "UNKNOWN" & !is.na(RACE)) %>%
  mutate(RACE = "Total")

adsl <- bind_rows(totalrace1, adsl)

adsl <- adsl %>%
  mutate(
    RACEcat = case_when(
      RACE == "Total" ~ "Total",
      RACE == "WHITE" ~ "White",
      RACE == "BLACK OR AFRICAN AMERICAN" ~ "Black",
      RACE == "ASIAN" ~ "Asian",
      RACE != "UNKNOWN" & !is.na(RACE) ~ "Other"
    )
  ) %>%
  filter(RACEcat %in% c("Total", "White", "Black", "Asian", "Other")) %>%
  select(-RACE)

adsl$spanheader <- factor(
  ifelse(adsl$RACEcat == "Total", " ", "Race"),
  levels = c(" ", "Race")
)

adsl$RACEcat <- factor(
  adsl$RACEcat,
  levels = c("Total", "White", "Black", "Asian", "Other")
)

# Add total for Race - adae
totalrace2 <- adae %>%
  filter(RACE != "UNKNOWN" & !is.na(RACE)) %>%
  mutate(RACE = "Total")

adae <- bind_rows(totalrace2, adae)

adae <- adae %>%
  mutate(
    RACEcat = case_when(
      RACE == "Total" ~ "Total",
      RACE == "WHITE" ~ "White",
      RACE == "BLACK OR AFRICAN AMERICAN" ~ "Black",
      RACE == "ASIAN" ~ "Asian",
      RACE != "UNKNOWN" & !is.na(RACE) ~ "Other"
    )
  ) %>%
  filter(RACEcat %in% c("Total", "White", "Black", "Asian", "Other")) %>%
  select(-RACE)

adae$RACEcat <- factor(
  adae$RACEcat,
  levels = c("Total", "White", "Black", "Asian", "Other")
)

# join data together
ae <- left_join(adsl, adae, by = c("USUBJID", "RACEcat"))

# Define layout and build table:

extra_args_1 <- list(
  denom = "n_altdf",
  .stats = c("count_unique_fraction")
)


extra_args_2 <- list(
  denom = "n_altdf",
  .stats = c("count_unique")
)


lyt <- basic_table(
  top_level_section_div = " ",
  show_colcounts = FALSE
) %>%
  split_cols_by(
    "colspan_trt",
    split_fun = trim_levels_to_map(map = colspan_trt_map)
  )

if (combined_colspan_trt == TRUE) {
  lyt <- lyt %>%
    split_cols_by(trtvar, split_fun = mysplit)
} else {
  lyt <- lyt %>%
    split_cols_by(trtvar)
}

lyt <- lyt %>%
  split_cols_by("spanheader", split_fun = trim_levels_in_group("RACEcat")) %>%
  split_cols_by("RACEcat") %>%
  analyze(
    popfl,
    afun = a_freq_j,
    show_labels = "hidden",
    section_div = c(" "),
    extra_args = append(
      extra_args_2,
      list(
        label = "Analysis set: Safety",
        val = "Y",
        section_div = c(" ")
      )
    )
  ) %>%
  analyze(
    "TRTEMFL",
    afun = a_freq_j,
    show_labels = "hidden",
    extra_args = append(
      extra_args_1,
      list(
        label = "Subjects with >=1 AE",
        val = "Y",
        section_div = c(" ")
      )
    )
  ) %>%
  split_rows_by(
    "AEBODSYS",
    split_label = "System Organ Class",
    split_fun = trim_levels_in_group("AEDECOD"),
    label_pos = "topleft",
    section_div = c(" "),
    nested = FALSE
  ) %>%
  summarize_row_groups(
    "AEBODSYS",
    cfun = a_freq_j,
    extra_args = extra_args_1
  ) %>%
  analyze("AEDECOD", afun = a_freq_j, extra_args = extra_args_1) %>%
  append_topleft("  Preferred Term, n (%)")

result <- build_table(lyt, ae, alt_counts_df = adsl)

# Post-Processing step to sort by descending count on chosen active treatment columns.

# col_paths_summary(result)

if (length(adae$TRTEMFL) != 0) {
  result <- sort_at_path(
    result,
    c("root", "AEBODSYS"),
    scorefun = jj_complex_scorefun(
      colpath = c(
        "colspan_trt",
        "Active Study Agent",
        trtvar,
        "Combined",
        "spanheader",
        " ",
        "RACEcat",
        "Total"
      )
    )
  )
  result <- sort_at_path(
    result,
    c("root", "AEBODSYS", "*", "AEDECOD"),
    scorefun = jj_complex_scorefun(
      colpath = c(
        "colspan_trt",
        "Active Study Agent",
        trtvar,
        "Combined",
        "spanheader",
        " ",
        "RACEcat",
        "Total"
      )
    )
  )
}

# Add titles and footnotes:

result <- set_titles(result, tab_titles)

# Convert to tbl file and output table

tt_to_tlgrtf(string_map = string_map, tt = 
  result,
  file = fileid,
  orientation = "portrait",
  label_width_ins = 1.5,
  nosplitin = list(cols = c(trtvar))
)

TSFAE22a: Subjects With Treatment-emergent Adverse Events by System Organ Class, Preferred Term, and Race; Safety Analysis Set (Study jjcs - core)

Active Study Agent

Xanomeline High Dose

Xanomeline Low Dose

Combined

Placebo

System Organ Class

Race

Race

Race

Race

Preferred Term, n (%)

Total

White

Black

Asian

Other

Total

White

Black

Asian

Other

Total

White

Black

Asian

Other

Total

White

Black

Asian

Other

Analysis set: Safety

47

8

3

10

26

68

8

11

9

40

115

16

14

19

66

51

7

7

5

32

Subjects with ≥1 AE

46 (97.9%)

8 (100.0%)

3 (100.0%)

10 (100.0%)

25 (96.2%)

58 (85.3%)

7 (87.5%)

8 (72.7%)

9 (100.0%)

34 (85.0%)

104 (90.4%)

15 (93.8%)

11 (78.6%)

19 (100.0%)

59 (89.4%)

36 (70.6%)

5 (71.4%)

5 (71.4%)

5 (100.0%)

21 (65.6%)

General disorders and
 administration site conditions

22 (46.8%)

5 (62.5%)

2 (66.7%)

4 (40.0%)

11 (42.3%)

36 (52.9%)

3 (37.5%)

4 (36.4%)

7 (77.8%)

22 (55.0%)

58 (50.4%)

8 (50.0%)

6 (42.9%)

11 (57.9%)

33 (50.0%)

14 (27.5%)

3 (42.9%)

0

2 (40.0%)

9 (28.1%)

APPLICATION SITE PRURITUS

12 (25.5%)

1 (12.5%)

0

3 (30.0%)

8 (30.8%)

17 (25.0%)

0

2 (18.2%)

3 (33.3%)

12 (30.0%)

29 (25.2%)

1 (6.2%)

2 (14.3%)

6 (31.6%)

20 (30.3%)

3 (5.9%)

1 (14.3%)

0

1 (20.0%)

1 (3.1%)

APPLICATION SITE ERYTHEMA

9 (19.1%)

1 (12.5%)

0

3 (30.0%)

5 (19.2%)

10 (14.7%)

0

1 (9.1%)

2 (22.2%)

7 (17.5%)

19 (16.5%)

1 (6.2%)

1 (7.1%)

5 (26.3%)

12 (18.2%)

2 (3.9%)

1 (14.3%)

0

0

1 (3.1%)

APPLICATION SITE IRRITATION

5 (10.6%)

1 (12.5%)

0

0

4 (15.4%)

7 (10.3%)

1 (12.5%)

1 (9.1%)

1 (11.1%)

4 (10.0%)

12 (10.4%)

2 (12.5%)

1 (7.1%)

1 (5.3%)

8 (12.1%)

2 (3.9%)

0

0

1 (20.0%)

1 (3.1%)

APPLICATION SITE DERMATITIS

4 (8.5%)

1 (12.5%)

1 (33.3%)

0

2 (7.7%)

7 (10.3%)

0

2 (18.2%)

0

5 (12.5%)

11 (9.6%)

1 (6.2%)

3 (21.4%)

0

7 (10.6%)

5 (9.8%)

1 (14.3%)

0

1 (20.0%)

3 (9.4%)

APPLICATION SITE VESICLES

3 (6.4%)

0

0

0

3 (11.5%)

4 (5.9%)

0

0

1 (11.1%)

3 (7.5%)

7 (6.1%)

0

0

1 (5.3%)

6 (9.1%)

0

0

0

0

0

FATIGUE

3 (6.4%)

2 (25.0%)

1 (33.3%)

0

0

3 (4.4%)

0

1 (9.1%)

1 (11.1%)

1 (2.5%)

6 (5.2%)

2 (12.5%)

2 (14.3%)

1 (5.3%)

1 (1.5%)

0

0

0

0

0

APPLICATION SITE SWELLING

2 (4.3%)

1 (12.5%)

0

1 (10.0%)

0

1 (1.5%)

0

0

0

1 (2.5%)

3 (2.6%)

1 (6.2%)

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

APPLICATION SITE
 PERSPIRATION

2 (4.3%)

1 (12.5%)

0

1 (10.0%)

0

0

0

0

0

0

2 (1.7%)

1 (6.2%)

0

1 (5.3%)

0

0

0

0

0

0

CHEST DISCOMFORT

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

0

0

1 (2.5%)

2 (1.7%)

0

0

0

2 (3.0%)

0

0

0

0

0

MALAISE

2 (4.3%)

0

0

1 (10.0%)

1 (3.8%)

0

0

0

0

0

2 (1.7%)

0

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

OEDEMA PERIPHERAL

1 (2.1%)

1 (12.5%)

0

0

0

1 (1.5%)

1 (12.5%)

0

0

0

2 (1.7%)

2 (12.5%)

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

APPLICATION SITE BLEEDING

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

APPLICATION SITE
 DESQUAMATION

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

APPLICATION SITE PAIN

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

APPLICATION SITE REACTION

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

1 (2.0%)

0

0

0

1 (3.1%)

APPLICATION SITE URTICARIA

0

0

0

0

0

1 (1.5%)

1 (12.5%)

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

ASTHENIA

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

1 (2.0%)

0

0

0

1 (3.1%)

CHEST PAIN

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

CHILLS

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

FEELING ABNORMAL

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

FEELING COLD

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

OEDEMA

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

PAIN

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

PYREXIA

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

2 (3.9%)

0

0

0

2 (6.2%)

SECRETION DISCHARGE

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

SUDDEN DEATH

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

ULCER

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

0

0

0

0

0

APPLICATION SITE INDURATION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Skin and subcutaneous tissue
 disorders

32 (68.1%)

7 (87.5%)

1 (33.3%)

8 (80.0%)

16 (61.5%)

26 (38.2%)

4 (50.0%)

4 (36.4%)

4 (44.4%)

14 (35.0%)

58 (50.4%)

11 (68.8%)

5 (35.7%)

12 (63.2%)

30 (45.5%)

12 (23.5%)

2 (28.6%)

2 (28.6%)

1 (20.0%)

7 (21.9%)

PRURITUS

18 (38.3%)

3 (37.5%)

1 (33.3%)

4 (40.0%)

10 (38.5%)

14 (20.6%)

3 (37.5%)

1 (9.1%)

2 (22.2%)

8 (20.0%)

32 (27.8%)

6 (37.5%)

2 (14.3%)

6 (31.6%)

18 (27.3%)

4 (7.8%)

1 (14.3%)

1 (14.3%)

0

2 (6.2%)

ERYTHEMA

10 (21.3%)

3 (37.5%)

1 (33.3%)

0

6 (23.1%)

8 (11.8%)

1 (12.5%)

1 (9.1%)

0

6 (15.0%)

18 (15.7%)

4 (25.0%)

2 (14.3%)

0

12 (18.2%)

4 (7.8%)

0

2 (28.6%)

0

2 (6.2%)

RASH

5 (10.6%)

0

0

2 (20.0%)

3 (11.5%)

8 (11.8%)

3 (37.5%)

2 (18.2%)

1 (11.1%)

2 (5.0%)

13 (11.3%)

3 (18.8%)

2 (14.3%)

3 (15.8%)

5 (7.6%)

3 (5.9%)

1 (14.3%)

0

1 (20.0%)

1 (3.1%)

HYPERHIDROSIS

7 (14.9%)

2 (25.0%)

0

3 (30.0%)

2 (7.7%)

3 (4.4%)

0

0

2 (22.2%)

1 (2.5%)

10 (8.7%)

2 (12.5%)

0

5 (26.3%)

3 (4.5%)

0

0

0

0

0

SKIN IRRITATION

4 (8.5%)

1 (12.5%)

0

2 (20.0%)

1 (3.8%)

4 (5.9%)

0

0

1 (11.1%)

3 (7.5%)

8 (7.0%)

1 (6.2%)

0

3 (15.8%)

4 (6.1%)

3 (5.9%)

0

1 (14.3%)

0

2 (6.2%)

BLISTER

1 (2.1%)

0

0

0

1 (3.8%)

2 (2.9%)

0

0

0

2 (5.0%)

3 (2.6%)

0

0

0

3 (4.5%)

0

0

0

0

0

RASH PRURITIC

2 (4.3%)

1 (12.5%)

0

0

1 (3.8%)

1 (1.5%)

0

1 (9.1%)

0

0

3 (2.6%)

1 (6.2%)

1 (7.1%)

0

1 (1.5%)

0

0

0

0

0

URTICARIA

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

1 (12.5%)

0

0

0

2 (1.7%)

1 (6.2%)

0

0

1 (1.5%)

0

0

0

0

0

ACTINIC KERATOSIS

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

PRURITUS GENERALISED

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

RASH ERYTHEMATOUS

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

RASH MACULO-PAPULAR

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

SKIN ODOUR ABNORMAL

1 (2.1%)

1 (12.5%)

0

0

0

0

0

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

ALOPECIA

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

DRUG ERUPTION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

1 (20.0%)

0

SKIN ULCER

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Nervous system disorders

17 (36.2%)

3 (37.5%)

1 (33.3%)

3 (30.0%)

10 (38.5%)

16 (23.5%)

1 (12.5%)

2 (18.2%)

3 (33.3%)

10 (25.0%)

33 (28.7%)

4 (25.0%)

3 (21.4%)

6 (31.6%)

20 (30.3%)

5 (9.8%)

0

0

1 (20.0%)

4 (12.5%)

DIZZINESS

8 (17.0%)

1 (12.5%)

0

2 (20.0%)

5 (19.2%)

6 (8.8%)

0

0

1 (11.1%)

5 (12.5%)

14 (12.2%)

1 (6.2%)

0

3 (15.8%)

10 (15.2%)

0

0

0

0

0

HEADACHE

5 (10.6%)

0

0

1 (10.0%)

4 (15.4%)

3 (4.4%)

0

0

1 (11.1%)

2 (5.0%)

8 (7.0%)

0

0

2 (10.5%)

6 (9.1%)

2 (3.9%)

0

0

0

2 (6.2%)

SYNCOPE

1 (2.1%)

0

1 (33.3%)

0

0

3 (4.4%)

1 (12.5%)

0

0

2 (5.0%)

4 (3.5%)

1 (6.2%)

1 (7.1%)

0

2 (3.0%)

0

0

0

0

0

SOMNOLENCE

1 (2.1%)

0

0

1 (10.0%)

0

2 (2.9%)

0

0

1 (11.1%)

1 (2.5%)

3 (2.6%)

0

0

2 (10.5%)

1 (1.5%)

1 (2.0%)

0

0

0

1 (3.1%)

TRANSIENT ISCHAEMIC
 ATTACK

1 (2.1%)

1 (12.5%)

0

0

0

2 (2.9%)

0

0

1 (11.1%)

1 (2.5%)

3 (2.6%)

1 (6.2%)

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

BALANCE DISORDER

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

0

0

0

0

0

BURNING SENSATION

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

COGNITIVE DISORDER

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

COMPLEX PARTIAL SEIZURES

0

0

0

0

0

1 (1.5%)

1 (12.5%)

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

COORDINATION ABNORMAL

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

0

0

0

0

0

HEMIANOPIA HOMONYMOUS

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

HYPERSOMNIA

1 (2.1%)

0

1 (33.3%)

0

0

0

0

0

0

0

1 (0.9%)

0

1 (7.1%)

0

0

0

0

0

0

0

LETHARGY

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

PARAESTHESIA

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

PARAESTHESIA ORAL

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

0

0

0

0

0

PAROSMIA

1 (2.1%)

1 (12.5%)

0

0

0

0

0

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

STUPOR

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

SYNCOPE VASOVAGAL

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

PARKINSON'S DISEASE

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

PSYCHOMOTOR
 HYPERACTIVITY

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

1 (20.0%)

0

Gastrointestinal disorders

13 (27.7%)

2 (25.0%)

0

4 (40.0%)

7 (26.9%)

9 (13.2%)

0

2 (18.2%)

2 (22.2%)

5 (12.5%)

22 (19.1%)

2 (12.5%)

2 (14.3%)

6 (31.6%)

12 (18.2%)

5 (9.8%)

0

0

0

5 (15.6%)

VOMITING

5 (10.6%)

2 (25.0%)

0

2 (20.0%)

1 (3.8%)

2 (2.9%)

0

0

0

2 (5.0%)

7 (6.1%)

2 (12.5%)

0

2 (10.5%)

3 (4.5%)

0

0

0

0

0

DIARRHOEA

2 (4.3%)

0

0

0

2 (7.7%)

3 (4.4%)

0

0

1 (11.1%)

2 (5.0%)

5 (4.3%)

0

0

1 (5.3%)

4 (6.1%)

2 (3.9%)

0

0

0

2 (6.2%)

NAUSEA

4 (8.5%)

2 (25.0%)

0

0

2 (7.7%)

1 (1.5%)

0

0

0

1 (2.5%)

5 (4.3%)

2 (12.5%)

0

0

3 (4.5%)

0

0

0

0

0

SALIVARY HYPERSECRETION

4 (8.5%)

1 (12.5%)

0

1 (10.0%)

2 (7.7%)

0

0

0

0

0

4 (3.5%)

1 (6.2%)

0

1 (5.3%)

2 (3.0%)

0

0

0

0

0

ABDOMINAL PAIN

0

0

0

0

0

2 (2.9%)

0

1 (9.1%)

0

1 (2.5%)

2 (1.7%)

0

1 (7.1%)

0

1 (1.5%)

0

0

0

0

0

ABDOMINAL DISCOMFORT

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

DYSPEPSIA

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

1 (2.0%)

0

0

0

1 (3.1%)

RECTAL HAEMORRHAGE

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

STOMACH DISCOMFORT

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

GASTROOESOPHAGEAL REFLUX
 DISEASE

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

GLOSSITIS

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

HIATUS HERNIA

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Cardiac disorders

11 (23.4%)

1 (12.5%)

0

4 (40.0%)

6 (23.1%)

9 (13.2%)

0

2 (18.2%)

1 (11.1%)

6 (15.0%)

20 (17.4%)

1 (6.2%)

2 (14.3%)

5 (26.3%)

12 (18.2%)

6 (11.8%)

1 (14.3%)

3 (42.9%)

0

2 (6.2%)

SINUS BRADYCARDIA

7 (14.9%)

1 (12.5%)

0

2 (20.0%)

4 (15.4%)

3 (4.4%)

0

0

0

3 (7.5%)

10 (8.7%)

1 (6.2%)

0

2 (10.5%)

7 (10.6%)

0

0

0

0

0

MYOCARDIAL INFARCTION

3 (6.4%)

0

0

2 (20.0%)

1 (3.8%)

1 (1.5%)

0

0

0

1 (2.5%)

4 (3.5%)

0

0

2 (10.5%)

2 (3.0%)

2 (3.9%)

1 (14.3%)

1 (14.3%)

0

0

VENTRICULAR EXTRASYSTOLES

1 (2.1%)

0

0

1 (10.0%)

0

2 (2.9%)

0

1 (9.1%)

0

1 (2.5%)

3 (2.6%)

0

1 (7.1%)

1 (5.3%)

1 (1.5%)

0

0

0

0

0

ATRIAL FIBRILLATION

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

0

0

1 (2.5%)

2 (1.7%)

0

0

0

2 (3.0%)

0

0

0

0

0

ATRIAL FLUTTER

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

1 (9.1%)

0

0

2 (1.7%)

0

1 (7.1%)

0

1 (1.5%)

0

0

0

0

0

ATRIOVENTRICULAR BLOCK
 FIRST DEGREE

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

BUNDLE BRANCH BLOCK RIGHT

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

1 (2.0%)

0

1 (14.3%)

0

0

CARDIAC DISORDER

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

PALPITATIONS

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

SUPRAVENTRICULAR
 EXTRASYSTOLES

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

1 (2.0%)

0

1 (14.3%)

0

0

SUPRAVENTRICULAR
 TACHYCARDIA

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

WOLFF-PARKINSON-WHITE
 SYNDROME

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

ATRIOVENTRICULAR BLOCK
 SECOND DEGREE

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

1 (14.3%)

0

0

BUNDLE BRANCH BLOCK LEFT

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

SINUS ARRHYTHMIA

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

TACHYCARDIA

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

1 (14.3%)

0

0

Infections and infestations

9 (19.1%)

1 (12.5%)

1 (33.3%)

3 (30.0%)

4 (15.4%)

6 (8.8%)

1 (12.5%)

2 (18.2%)

0

3 (7.5%)

15 (13.0%)

2 (12.5%)

3 (21.4%)

3 (15.8%)

7 (10.6%)

12 (23.5%)

0

2 (28.6%)

2 (40.0%)

8 (25.0%)

NASOPHARYNGITIS

3 (6.4%)

0

0

0

3 (11.5%)

3 (4.4%)

0

2 (18.2%)

0

1 (2.5%)

6 (5.2%)

0

2 (14.3%)

0

4 (6.1%)

2 (3.9%)

0

0

2 (40.0%)

0

INFLUENZA

1 (2.1%)

0

0

1 (10.0%)

0

1 (1.5%)

0

0

0

1 (2.5%)

2 (1.7%)

0

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

UPPER RESPIRATORY TRACT
 INFECTION

2 (4.3%)

1 (12.5%)

1 (33.3%)

0

0

0

0

0

0

0

2 (1.7%)

1 (6.2%)

1 (7.1%)

0

0

5 (9.8%)

0

1 (14.3%)

0

4 (12.5%)

CELLULITIS

0

0

0

0

0

1 (1.5%)

1 (12.5%)

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

HORDEOLUM

1 (2.1%)

1 (12.5%)

0

0

0

0

0

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

LOWER RESPIRATORY TRACT
 INFECTION

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

PNEUMONIA

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

RHINITIS

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

URINARY TRACT INFECTION

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

2 (3.9%)

0

0

0

2 (6.2%)

BRONCHITIS

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

1 (14.3%)

0

0

CERVICITIS

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

EAR INFECTION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

GASTROENTERITIS VIRAL

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

LOCALISED INFECTION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

VAGINAL MYCOSIS

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Respiratory, thoracic and
 mediastinal disorders

7 (14.9%)

1 (12.5%)

0

1 (10.0%)

5 (19.2%)

5 (7.4%)

0

0

0

5 (12.5%)

12 (10.4%)

1 (6.2%)

0

1 (5.3%)

10 (15.2%)

5 (9.8%)

1 (14.3%)

0

1 (20.0%)

3 (9.4%)

COUGH

3 (6.4%)

1 (12.5%)

0

0

2 (7.7%)

4 (5.9%)

0

0

0

4 (10.0%)

7 (6.1%)

1 (6.2%)

0

0

6 (9.1%)

1 (2.0%)

1 (14.3%)

0

0

0

NASAL CONGESTION

3 (6.4%)

1 (12.5%)

0

1 (10.0%)

1 (3.8%)

0

0

0

0

0

3 (2.6%)

1 (6.2%)

0

1 (5.3%)

1 (1.5%)

2 (3.9%)

0

0

0

2 (6.2%)

EPISTAXIS

2 (4.3%)

0

0

1 (10.0%)

1 (3.8%)

0

0

0

0

0

2 (1.7%)

0

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

RHINORRHOEA

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

0

0

1 (2.5%)

2 (1.7%)

0

0

0

2 (3.0%)

0

0

0

0

0

ALLERGIC GRANULOMATOUS
 ANGIITIS

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

DYSPNOEA

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

PHARYNGOLARYNGEAL PAIN

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

PRODUCTIVE COUGH

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

RESPIRATORY TRACT
 CONGESTION

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

EMPHYSEMA

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

1 (20.0%)

0

POSTNASAL DRIP

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Investigations

4 (8.5%)

1 (12.5%)

0

1 (10.0%)

2 (7.7%)

7 (10.3%)

0

0

1 (11.1%)

6 (15.0%)

11 (9.6%)

1 (6.2%)

0

2 (10.5%)

8 (12.1%)

6 (11.8%)

2 (28.6%)

2 (28.6%)

0

2 (6.2%)

BLOOD GLUCOSE INCREASED

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

0

0

1 (2.5%)

2 (1.7%)

0

0

0

2 (3.0%)

0

0

0

0

0

BIOPSY

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

BIOPSY PROSTATE

1 (2.1%)

1 (12.5%)

0

0

0

0

0

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

BLOOD CHOLESTEROL
 INCREASED

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

BODY TEMPERATURE
 INCREASED

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

ELECTROCARDIOGRAM ST
 SEGMENT DEPRESSION

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

3 (5.9%)

2 (28.6%)

1 (14.3%)

0

0

ELECTROCARDIOGRAM T WAVE
 AMPLITUDE DECREASED

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

ELECTROCARDIOGRAM T WAVE
 INVERSION

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

1 (2.0%)

0

1 (14.3%)

0

0

NASAL MUCOSA BIOPSY

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

WEIGHT DECREASED

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

BLOOD ALKALINE
 PHOSPHATASE INCREASED

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

1 (14.3%)

0

0

BLOOD CREATINE
 PHOSPHOKINASE INCREASED

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

BLOOD URINE PRESENT

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

CYSTOSCOPY

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Psychiatric disorders

5 (10.6%)

1 (12.5%)

0

3 (30.0%)

1 (3.8%)

6 (8.8%)

1 (12.5%)

0

1 (11.1%)

4 (10.0%)

11 (9.6%)

2 (12.5%)

0

4 (21.1%)

5 (7.6%)

7 (13.7%)

0

0

1 (20.0%)

6 (18.8%)

CONFUSIONAL STATE

1 (2.1%)

0

0

1 (10.0%)

0

2 (2.9%)

1 (12.5%)

0

0

1 (2.5%)

3 (2.6%)

1 (6.2%)

0

1 (5.3%)

1 (1.5%)

2 (3.9%)

0

0

0

2 (6.2%)

AGITATION

0

0

0

0

0

2 (2.9%)

0

0

0

2 (5.0%)

2 (1.7%)

0

0

0

2 (3.0%)

1 (2.0%)

0

0

0

1 (3.1%)

ANXIETY

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

DELIRIUM

1 (2.1%)

1 (12.5%)

0

0

0

0

0

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

DELUSION

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

1 (2.0%)

0

0

1 (20.0%)

0

HALLUCINATION

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

INSOMNIA

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

1 (2.0%)

0

0

0

1 (3.1%)

IRRITABILITY

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

LIBIDO DECREASED

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

LISTLESS

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

NIGHTMARE

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

RESTLESSNESS

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

DISORIENTATION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

DISTURBANCE IN SEXUAL
 AROUSAL

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Musculoskeletal and connective
 tissue disorders

4 (8.5%)

1 (12.5%)

0

1 (10.0%)

2 (7.7%)

5 (7.4%)

1 (12.5%)

0

0

4 (10.0%)

9 (7.8%)

2 (12.5%)

0

1 (5.3%)

6 (9.1%)

2 (3.9%)

2 (28.6%)

0

0

0

BACK PAIN

2 (4.3%)

1 (12.5%)

0

0

1 (3.8%)

1 (1.5%)

0

0

0

1 (2.5%)

3 (2.6%)

1 (6.2%)

0

0

2 (3.0%)

1 (2.0%)

1 (14.3%)

0

0

0

ARTHRALGIA

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

1 (12.5%)

0

0

0

2 (1.7%)

1 (6.2%)

0

0

1 (1.5%)

0

0

0

0

0

FLANK PAIN

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

MUSCLE SPASMS

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

MUSCULAR WEAKNESS

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

MYALGIA

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

SHOULDER PAIN

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

1 (2.0%)

1 (14.3%)

0

0

0

Injury, poisoning and
 procedural complications

3 (6.4%)

0

0

2 (20.0%)

1 (3.8%)

5 (7.4%)

1 (12.5%)

1 (9.1%)

0

3 (7.5%)

8 (7.0%)

1 (6.2%)

1 (7.1%)

2 (10.5%)

4 (6.1%)

2 (3.9%)

0

0

1 (20.0%)

1 (3.1%)

CONTUSION

2 (4.3%)

0

0

2 (20.0%)

0

1 (1.5%)

0

1 (9.1%)

0

0

3 (2.6%)

0

1 (7.1%)

2 (10.5%)

0

0

0

0

0

0

FALL

1 (2.1%)

0

0

1 (10.0%)

0

2 (2.9%)

1 (12.5%)

1 (9.1%)

0

0

3 (2.6%)

1 (6.2%)

1 (7.1%)

1 (5.3%)

0

1 (2.0%)

0

0

0

1 (3.1%)

EXCORIATION

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

0

0

1 (2.5%)

2 (1.7%)

0

0

0

2 (3.0%)

0

0

0

0

0

SKIN LACERATION

0

0

0

0

0

2 (2.9%)

1 (12.5%)

0

0

1 (2.5%)

2 (1.7%)

1 (6.2%)

0

0

1 (1.5%)

0

0

0

0

0

FACIAL BONES FRACTURE

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

JOINT DISLOCATION

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

WOUND

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

HIP FRACTURE

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

1 (20.0%)

0

Renal and urinary disorders

2 (4.3%)

0

0

1 (10.0%)

1 (3.8%)

3 (4.4%)

1 (12.5%)

0

1 (11.1%)

1 (2.5%)

5 (4.3%)

1 (6.2%)

0

2 (10.5%)

2 (3.0%)

2 (3.9%)

0

0

0

2 (6.2%)

CALCULUS URETHRAL

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

DYSURIA

0

0

0

0

0

1 (1.5%)

0

0

1 (11.1%)

0

1 (0.9%)

0

0

1 (5.3%)

0

1 (2.0%)

0

0

0

1 (3.1%)

INCONTINENCE

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

MICTURITION URGENCY

0

0

0

0

0

1 (1.5%)

1 (12.5%)

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

NEPHROLITHIASIS

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

Vascular disorders

1 (2.1%)

0

0

0

1 (3.8%)

3 (4.4%)

0

0

0

3 (7.5%)

4 (3.5%)

0

0

0

4 (6.1%)

3 (5.9%)

0

1 (14.3%)

0

2 (6.2%)

HOT FLUSH

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

HYPERTENSION

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

1 (2.0%)

0

0

0

1 (3.1%)

HYPOTENSION

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

2 (3.9%)

0

1 (14.3%)

0

1 (3.1%)

WOUND HAEMORRHAGE

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

ORTHOSTATIC HYPOTENSION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Ear and labyrinth disorders

1 (2.1%)

0

0

0

1 (3.8%)

2 (2.9%)

0

1 (9.1%)

1 (11.1%)

0

3 (2.6%)

0

1 (7.1%)

1 (5.3%)

1 (1.5%)

1 (2.0%)

0

1 (14.3%)

0

0

VERTIGO

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

0

1 (11.1%)

0

2 (1.7%)

0

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

CERUMEN IMPACTION

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

0

0

0

0

0

EAR PAIN

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

1 (14.3%)

0

0

Eye disorders

1 (2.1%)

0

0

0

1 (3.8%)

2 (2.9%)

0

1 (9.1%)

1 (11.1%)

0

3 (2.6%)

0

1 (7.1%)

1 (5.3%)

1 (1.5%)

2 (3.9%)

0

0

0

2 (6.2%)

VISION BLURRED

1 (2.1%)

0

0

0

1 (3.8%)

1 (1.5%)

0

0

1 (11.1%)

0

2 (1.7%)

0

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

CONJUNCTIVAL HAEMORRHAGE

0

0

0

0

0

1 (1.5%)

0

1 (9.1%)

0

0

1 (0.9%)

0

1 (7.1%)

0

0

0

0

0

0

0

CONJUNCTIVITIS

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

EYE ALLERGY

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

EYE PRURITUS

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

EYE SWELLING

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Reproductive system and breast
 disorders

3 (6.4%)

2 (25.0%)

0

1 (10.0%)

0

0

0

0

0

0

3 (2.6%)

2 (12.5%)

0

1 (5.3%)

0

3 (5.9%)

0

1 (14.3%)

0

2 (6.2%)

ABNORMAL UTERINE BLEEDING

1 (2.1%)

1 (12.5%)

0

0

0

0

0

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

0

0

0

0

0

BENIGN PROSTATIC
 HYPERPLASIA

1 (2.1%)

1 (12.5%)

0

0

0

0

0

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

ERECTILE DYSFUNCTION

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

1 (2.0%)

0

1 (14.3%)

0

0

PELVIC PAIN

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Congenital, familial and genetic
 disorders

1 (2.1%)

0

0

1 (10.0%)

0

1 (1.5%)

0

1 (9.1%)

0

0

2 (1.7%)

0

1 (7.1%)

1 (5.3%)

0

0

0

0

0

0

VENTRICULAR SEPTAL DEFECT

1 (2.1%)

0

0

1 (10.0%)

0

1 (1.5%)

0

1 (9.1%)

0

0

2 (1.7%)

0

1 (7.1%)

1 (5.3%)

0

0

0

0

0

0

Neoplasms benign, malignant
 and unspecified (incl cysts
 and polyps)

1 (2.1%)

0

0

1 (10.0%)

0

1 (1.5%)

0

0

0

1 (2.5%)

2 (1.7%)

0

0

1 (5.3%)

1 (1.5%)

0

0

0

0

0

COLON CANCER

0

0

0

0

0

1 (1.5%)

0

0

0

1 (2.5%)

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

PROSTATE CANCER

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

Endocrine disorders

0

0

0

0

0

1 (1.5%)

1 (12.5%)

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

1 (2.0%)

1 (14.3%)

0

0

0

BLEEDING ANOVULATORY

0

0

0

0

0

1 (1.5%)

1 (12.5%)

0

0

0

1 (0.9%)

1 (6.2%)

0

0

0

1 (2.0%)

1 (14.3%)

0

0

0

Metabolism and nutrition
 disorders

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

2 (3.9%)

0

0

0

2 (6.2%)

INCREASED APPETITE

1 (2.1%)

0

0

1 (10.0%)

0

0

0

0

0

0

1 (0.9%)

0

0

1 (5.3%)

0

0

0

0

0

0

DECREASED APPETITE

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

DEHYDRATION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Surgical and medical
 procedures

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

2 (3.9%)

0

0

0

2 (6.2%)

ACROCHORDON EXCISION

1 (2.1%)

0

0

0

1 (3.8%)

0

0

0

0

0

1 (0.9%)

0

0

0

1 (1.5%)

0

0

0

0

0

CATARACT OPERATION

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

EYE LASER SURGERY

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1 (2.0%)

0

0

0

1 (3.1%)

Note: Subjects whose race was unknown or not reported are excluded from the summary.

Note: Subjects are counted only once for any given event, regardless of the number of times they actually experienced the event.

Note: Adverse events are coded using MedDRA version 26.0.

Download RTF file

TSFAE21D
TSFAE22B
Source Code
---
title: TSFAE22A
subtitle: Subjects With Treatment-emergent Adverse Events by System Organ Class, Preferred Term, and Race
---

------------------------------------------------------------------------

{{< include ../../_utils/envir_hook.qmd >}}

```{r setup, echo = FALSE, warning = FALSE, message = FALSE}
options(docx.add_datetime = FALSE, tidytlg.add_datetime = FALSE)
envsetup_config_name <- "default"

# Path to the combined config file
envsetup_file_path <- file.path("../..", "envsetup.yml")

Sys.setenv(ENVSETUP_ENVIRON = '')
library(envsetup)
loaded_config <- config::get(config = envsetup_config_name, file = envsetup_file_path)
envsetup::rprofile(loaded_config)


dpscomp <- compound
dpspdr <- paste(protocol,dbrelease,rpteff,sep="__")

aptcomp <- compound
aptpdr <- paste(protocol,dbrelease,rpteff,sep="__")

###### Study specific updates (formerly in envre)

dpscomp <- "standards"
dpspdr <- "jjcs__NULL__jjcs - core"

apt <- FALSE
library(junco)
default_str_map <- rbind(default_str_map, c("&ctcae", "5.0"))

```

## Output

:::: panel-tabset
## {{< fa regular file-lines sm fw >}} Preview

```{r variant1, results='hide', warning = FALSE, message = FALSE}

# Program Name: tsfae22a.R

# Prep Environment

library(envsetup)
library(tern)
library(dplyr)
library(rtables)
library(junco)

# Define script level parameters:

# - Define output ID and file location

tblid <- "TSFAE22a"
fileid <- tblid
tab_titles <- get_titles_from_file(input_path = '../../_data/', tblid)
string_map <- default_str_map


trtvar <- "TRT01A"
popfl <- "SAFFL"
combined_colspan_trt <- TRUE

if (combined_colspan_trt == TRUE) {
  # Set up levels and label for the required combined columns
  add_combo <- add_combo_facet(
    "Combined",
    label = "Combined",
    levels = c("Xanomeline High Dose", "Xanomeline Low Dose")
  )

  # choose if any facets need to be removed - e.g remove the combined column for placebo
  rm_combo_from_placebo <- cond_rm_facets(
    facets = "Combined",
    ancestor_pos = NA,
    value = " ",
    split = "colspan_trt"
  )

  mysplit <- make_split_fun(post = list(add_combo, rm_combo_from_placebo))
}

# Process Data:

adsl <- pharmaverseadamjnj::adsl %>%
  filter(!!rlang::sym(popfl) == "Y") %>%
  select(STUDYID, USUBJID, all_of(trtvar), all_of(popfl), RACE)

adae <- pharmaverseadamjnj::adae %>%
  filter(TRTEMFL == "Y") %>%
  select(USUBJID, TRTEMFL, AEBODSYS, AEDECOD, RACE)

adsl$colspan_trt <- factor(
  ifelse(adsl[[trtvar]] == "Placebo", " ", "Active Study Agent"),
  levels = c("Active Study Agent", " ")
)

colspan_trt_map <- create_colspan_map(
  adsl,
  non_active_grp = "Placebo",
  non_active_grp_span_lbl = " ",
  active_grp_span_lbl = "Active Study Agent",
  colspan_var = "colspan_trt",
  trt_var = trtvar
)

# Add total for Race - adsl
totalrace1 <- adsl %>%
  filter(RACE != "UNKNOWN" & !is.na(RACE)) %>%
  mutate(RACE = "Total")

adsl <- bind_rows(totalrace1, adsl)

adsl <- adsl %>%
  mutate(
    RACEcat = case_when(
      RACE == "Total" ~ "Total",
      RACE == "WHITE" ~ "White",
      RACE == "BLACK OR AFRICAN AMERICAN" ~ "Black",
      RACE == "ASIAN" ~ "Asian",
      RACE != "UNKNOWN" & !is.na(RACE) ~ "Other"
    )
  ) %>%
  filter(RACEcat %in% c("Total", "White", "Black", "Asian", "Other")) %>%
  select(-RACE)

adsl$spanheader <- factor(
  ifelse(adsl$RACEcat == "Total", " ", "Race"),
  levels = c(" ", "Race")
)

adsl$RACEcat <- factor(
  adsl$RACEcat,
  levels = c("Total", "White", "Black", "Asian", "Other")
)

# Add total for Race - adae
totalrace2 <- adae %>%
  filter(RACE != "UNKNOWN" & !is.na(RACE)) %>%
  mutate(RACE = "Total")

adae <- bind_rows(totalrace2, adae)

adae <- adae %>%
  mutate(
    RACEcat = case_when(
      RACE == "Total" ~ "Total",
      RACE == "WHITE" ~ "White",
      RACE == "BLACK OR AFRICAN AMERICAN" ~ "Black",
      RACE == "ASIAN" ~ "Asian",
      RACE != "UNKNOWN" & !is.na(RACE) ~ "Other"
    )
  ) %>%
  filter(RACEcat %in% c("Total", "White", "Black", "Asian", "Other")) %>%
  select(-RACE)

adae$RACEcat <- factor(
  adae$RACEcat,
  levels = c("Total", "White", "Black", "Asian", "Other")
)

# join data together
ae <- left_join(adsl, adae, by = c("USUBJID", "RACEcat"))

# Define layout and build table:

extra_args_1 <- list(
  denom = "n_altdf",
  .stats = c("count_unique_fraction")
)


extra_args_2 <- list(
  denom = "n_altdf",
  .stats = c("count_unique")
)


lyt <- basic_table(
  top_level_section_div = " ",
  show_colcounts = FALSE
) %>%
  split_cols_by(
    "colspan_trt",
    split_fun = trim_levels_to_map(map = colspan_trt_map)
  )

if (combined_colspan_trt == TRUE) {
  lyt <- lyt %>%
    split_cols_by(trtvar, split_fun = mysplit)
} else {
  lyt <- lyt %>%
    split_cols_by(trtvar)
}

lyt <- lyt %>%
  split_cols_by("spanheader", split_fun = trim_levels_in_group("RACEcat")) %>%
  split_cols_by("RACEcat") %>%
  analyze(
    popfl,
    afun = a_freq_j,
    show_labels = "hidden",
    section_div = c(" "),
    extra_args = append(
      extra_args_2,
      list(
        label = "Analysis set: Safety",
        val = "Y",
        section_div = c(" ")
      )
    )
  ) %>%
  analyze(
    "TRTEMFL",
    afun = a_freq_j,
    show_labels = "hidden",
    extra_args = append(
      extra_args_1,
      list(
        label = "Subjects with >=1 AE",
        val = "Y",
        section_div = c(" ")
      )
    )
  ) %>%
  split_rows_by(
    "AEBODSYS",
    split_label = "System Organ Class",
    split_fun = trim_levels_in_group("AEDECOD"),
    label_pos = "topleft",
    section_div = c(" "),
    nested = FALSE
  ) %>%
  summarize_row_groups(
    "AEBODSYS",
    cfun = a_freq_j,
    extra_args = extra_args_1
  ) %>%
  analyze("AEDECOD", afun = a_freq_j, extra_args = extra_args_1) %>%
  append_topleft("  Preferred Term, n (%)")

result <- build_table(lyt, ae, alt_counts_df = adsl)

# Post-Processing step to sort by descending count on chosen active treatment columns.

# col_paths_summary(result)

if (length(adae$TRTEMFL) != 0) {
  result <- sort_at_path(
    result,
    c("root", "AEBODSYS"),
    scorefun = jj_complex_scorefun(
      colpath = c(
        "colspan_trt",
        "Active Study Agent",
        trtvar,
        "Combined",
        "spanheader",
        " ",
        "RACEcat",
        "Total"
      )
    )
  )
  result <- sort_at_path(
    result,
    c("root", "AEBODSYS", "*", "AEDECOD"),
    scorefun = jj_complex_scorefun(
      colpath = c(
        "colspan_trt",
        "Active Study Agent",
        trtvar,
        "Combined",
        "spanheader",
        " ",
        "RACEcat",
        "Total"
      )
    )
  )
}

# Add titles and footnotes:

result <- set_titles(result, tab_titles)

# Convert to tbl file and output table

tt_to_tlgrtf(string_map = string_map, tt = 
  result,
  file = fileid,
  orientation = "portrait",
  label_width_ins = 1.5,
  nosplitin = list(cols = c(trtvar))
)
```
```{r result1, echo=FALSE, message=FALSE, warning=FALSE, test = list(result_v1 = "result")}
tt_to_flextable_j(result, tblid, string_map = string_map) 
```

[Download RTF file](`r paste0(tolower(tblid), '.rtf')`)
::::

Made with ❤️ by the J&J Team

  • Edit this page
  • Report an issue
Cookie Preferences